Loading clinical trials...
Loading clinical trials...
A Phase 2, Double-Blind, Proof of Concept Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder
Conditions
Interventions
Mazdutide
Placebo
Locations
25
United States
Headlands Research - Scottsdale
Scottsdale, Arizona, United States
Woodland Resarch Northwest/ERG
Rogers, Arkansas, United States
Ark Clinical Research - Fountain Valley
Fountain Valley, California, United States
Synergy San Diego
Lemon Grove, California, United States
Headlands Research-Artemis San Diego
San Diego, California, United States
Research Centers of America ( Hollywood )
Hollywood, Florida, United States
Start Date
February 6, 2025
Primary Completion Date
August 1, 2026
Completion Date
August 1, 2026
Last Updated
March 27, 2026
NCT07027839
NCT06552741
NCT07279558
NCT07341230
NCT05855668
NCT06985927
Lead Sponsor
Eli Lilly and Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions